APA (7th ed.) Citation

Zhong, J., Fei, K., Wu, L., Li, B., Wang, Z., Cheng, Y., . . . Wang, J. Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): Final OS and biomarker exploration of a randomized, double-blind, phase 3 trial. Nature Publishing Group.

Chicago Style (17th ed.) Citation

Zhong, Jia, et al. Toripalimab Plus Chemotherapy for First Line Treatment of Advanced Non-small Cell Lung Cancer (CHOICE-01): Final OS and Biomarker Exploration of a Randomized, Double-blind, Phase 3 Trial. Nature Publishing Group.

MLA (9th ed.) Citation

Zhong, Jia, et al. Toripalimab Plus Chemotherapy for First Line Treatment of Advanced Non-small Cell Lung Cancer (CHOICE-01): Final OS and Biomarker Exploration of a Randomized, Double-blind, Phase 3 Trial. Nature Publishing Group.